| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DENND2A_0007400 | Intron-Exon-Intron | chr7:140301203-140305109 | chr7:140601403-140605309 | 250 nt | 0.4680 |
| hsa_chr7_0197700 | Intergenic-Intergenic | chr7:140302308-140305601 | chr7:140602508-140605801 | 97 nt | 0.5567 |
| hsa_DENND2A_0007700 | Intron-Intron | chr7:140310933-140312886 | chr7:140611133-140613086 | 1954 nt | 0.4534 |
| hsa_DENND2A_0007800 | Intron-Intron | chr7:140313040-140314892 | chr7:140613240-140615092 | 1853 nt | 0.4414 |
| hsa_DENND2A_0007900 | Intron-Intron | chr7:140315602-140315948 | chr7:140615802-140616148 | 347 nt | 0.4207 |
| hsa_chr7_0197800 | Intergenic-Intergenic | chr7:140318262-140319000 | chr7:140618462-140619200 | 739 nt | 0.4181 |
| hsa_chr7_0197900 | Intergenic-Intergenic | chr7:140329321-140338212 | chr7:140629521-140638412 | 250 nt | 0.3160 |
| hsa_DENND2A_0008000 | Intron-Intron | chr7:140330143-140330633 | chr7:140630343-140630833 | 491 nt | 0.4562 |
| hsa_chr7_0198000 | Intergenic-Intergenic | chr7:140337770-140339504 | chr7:140637970-140639704 | 1735 nt | 0.4893 |
| hsa_DENND2A_0008100 | Intron-Intron | chr7:140360850-140371002 | chr7:140661050-140671202 | 250 nt | 0.4040 |
A study in humans demonstrated that the circDENND2A is significantly elevated in myocardial ischemia patients and enhanced under oxygen glucose deprivation treatment [Tian et al. DOI:10.3390/molecules26041155].